Neuromyelitis optica (NMOSD) trials, also abroad
60 open Neuromyelitis optica (NMOSD) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| China | 30 |
| United States | 17 |
| France | 9 |
| Germany | 4 |
| United Kingdom | 4 |
| All other countries |
The same trial often runs in several countries
A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) has 2 sites in Italy and runs in 9 countries. If a site near you is full, another one may still take people.
See A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) in all 9 countries